{"id":"https://openalex.org/W2150239642","doi":"https://doi.org/10.2337/diacare.28.2.445","title":"Regression of Sight-Threatening Macular Edema in Type 2 Diabetes Following Treatment With the Anti\u2013Tumor Necrosis Factor Monoclonal Antibody Infliximab","display_name":"Regression of Sight-Threatening Macular Edema in Type 2 Diabetes Following Treatment With the Anti\u2013Tumor Necrosis Factor Monoclonal Antibody Infliximab","publication_year":2005,"publication_date":"2005-02-01","ids":{"openalex":"https://openalex.org/W2150239642","doi":"https://doi.org/10.2337/diacare.28.2.445","mag":"2150239642","pmid":"https://pubmed.ncbi.nlm.nih.gov/15677814"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.28.2.445","doi":"https://doi.org/10.2337/diacare.28.2.445","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.28.2.445","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007341235","display_name":"Petros Paul Sfikakis","orcid":"https://orcid.org/0000-0001-5484-2930","observed_orcids":["https://orcid.org/0000-0001-5484-2930"]},"institutions":[{"id":"https://openalex.org/I4210114623","display_name":"Laiko General Hospital of Athens","ror":"https://ror.org/02dvs1389","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210114623"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Petros P. Sfikakis","raw_affiliation_strings":["First Department of Propedeutic Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Propedeutic Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece","institution_ids":["https://openalex.org/I4210114623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114041014","display_name":"Nikos N. Markomichelakis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105465","display_name":"General Hospital of Athens G. Genimatas","ror":"https://ror.org/00zq17821","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210105465"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Nikos Markomichelakis","raw_affiliation_strings":["Ocular Inflammation and Immunology Service, Gennimatas Hospital, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ocular Inflammation and Immunology Service, Gennimatas Hospital, Athens, Greece","institution_ids":["https://openalex.org/I4210105465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040083360","display_name":"GEORGE P. THEODOSSIADIS","orcid":"https://orcid.org/0000-0002-5571-3206","observed_orcids":["https://orcid.org/0000-0002-5571-3206"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George P. Theodossiadis","raw_affiliation_strings":["Department of Ophthalmology, Dynan Hospital, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Dynan Hospital, Athens, Greece","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063807162","display_name":"Vlassis G. Grigoropoulos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vlassis Grigoropoulos","raw_affiliation_strings":["Department of Ophthalmology, Dynan Hospital, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Dynan Hospital, Athens, Greece","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003533953","display_name":"Nikos Katsilambros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114623","display_name":"Laiko General Hospital of Athens","ror":"https://ror.org/02dvs1389","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210114623"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Nikos Katsilambros","raw_affiliation_strings":["First Department of Propedeutic Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Propedeutic Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece","institution_ids":["https://openalex.org/I4210114623"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054741532","display_name":"Panayiotis G. Theodossiadis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Panayiotis G. Theodossiadis","raw_affiliation_strings":["Department of Ophthalmology, Athens University Medical School, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Athens University Medical School, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.8907,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.94983728,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"28","issue":"2","first_page":"445","last_page":"447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.996999979019165},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8970000147819519},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8550000190734863},{"id":"https://openalex.org/keywords/anti-tnf-therapy","display_name":"anti-TNF therapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9290000200271606},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/cystoid-macular-edema","display_name":"cystoid macular edema","score":0.9269999861717224},{"id":"https://openalex.org/keywords/uveitis","display_name":"uveitis","score":0.8169999718666077},{"id":"https://openalex.org/keywords/refractory-macular-edema","display_name":"refractory macular edema","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9708372354507446},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8420217633247375},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.619122326374054},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5872558355331421},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5841245055198669},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5179754495620728},{"id":"https://openalex.org/C3020084786","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor \u03b1","level":3,"score":0.5073670744895935},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.48242005705833435},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4231332540512085},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.41855278611183167},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.27240169048309326},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2177477478981018},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1035260558128357}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2337/diacare.28.2.445","doi":"https://doi.org/10.2337/diacare.28.2.445","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.28.2.445","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:15677814","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15677814","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.848.4620","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.848.4620","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/28/2/445.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1577441858","https://openalex.org/W1984984255","https://openalex.org/W1996870435","https://openalex.org/W2014887512","https://openalex.org/W2016795705","https://openalex.org/W2036131677","https://openalex.org/W2037192832","https://openalex.org/W2065329000","https://openalex.org/W2067432336","https://openalex.org/W2074222374","https://openalex.org/W2120276758","https://openalex.org/W2147171610","https://openalex.org/W2160121103","https://openalex.org/W2169971427","https://openalex.org/W2326480835","https://openalex.org/W2546961712"],"related_works":["https://openalex.org/W7099797442","https://openalex.org/W2166438103","https://openalex.org/W1160949922","https://openalex.org/W2028253275","https://openalex.org/W4206521982","https://openalex.org/W1974610286","https://openalex.org/W2795227276","https://openalex.org/W1765305062","https://openalex.org/W3030089809","https://openalex.org/W2098151017"],"abstract_inverted_index":{"D":[0],"iabetic":[1],"retinopathy":[2],"and":[3,143,151,171],"diabeticmacular":[4],"edema":[5,187],"(DME)":[6],"are":[7,97,112],"leadingcauses":[8],"of":[9,15,21,29,35,44,51,59,76,81,87,93,124,132,163,166],"blindness":[10],"in":[11,24,90],"an":[12,55,69,105,181],"increasing":[13],"number":[14],"patients":[16,102],"with":[17,156,189],"diabetes":[18],"(1).":[19,108],"Re-duction":[20],"visual":[22],"aquity":[23],"DME":[25,52,79],"results":[26],"from":[27,32],"accumulation":[28],"fluid":[30],"produced":[31],"a":[33,157],"rupture":[34],"the":[36,40,45,49,60,85,164],"blood-retinal":[37],"barrier":[38],"into":[39],"inner":[41],"nuclear":[42],"layer":[43],"retina":[46],"(1,2).":[47],"Although":[48],"etiology":[50],"is":[53,180],"unclear,":[54],"altered":[56],"local":[57],"expression":[58,131],"pleiotropic":[61],"cytokine":[62],"tumor":[63],"necrosis":[64],"fac-tor":[65],"(TNF)":[66],"may":[67],"play":[68],"important":[70],"patho-genetic":[71],"role":[72],"(2\u20135).":[73],"Standard":[74],"treatment":[75],"clinically":[77],"significant":[78],"consisting":[80],"la-ser":[82],"photocoagulation":[83],"reduces":[84],"risk":[86],"vision":[88],"loss":[89],"60":[91],"%":[92],"cases,":[94],"but":[95],"recur-rences":[96],"common,":[98],"even":[99],"among":[100],"those":[101],"who":[103],"achieve":[104],"initial":[106],"response":[107],"Various":[109],"pharmacological":[110],"therapies":[111],"currently":[113],"under":[114],"study,":[115],"including":[116],"inta-vitreal":[117],"triamcinolone":[118],"injections":[119],"(6)":[120],"or":[121],"high":[122],"doses":[123],"nonsteroidal":[125],"anti-inflammatory":[126],"agents":[127],"that":[128,178],"lower":[129],"retinal":[130],"TNF":[133,141],"(7).":[134],"The":[135],"monoclonal":[136],"anti-TNF":[137],"antibody":[138],"Infliximab":[139,179,196],"neutralizes":[140],"actions":[142],"has":[144],"been":[145],"used":[146],"for":[147,169,184,197],"inflammatory":[148],"arthritic":[149],"conditions":[150],"Crohn\u2019s":[152],"disease":[153],"since":[154],"1998":[155],"favorable":[158],"safety":[159],"profile":[160],"(8).":[161],"Because":[162],"limitations":[165],"current":[167],"treat-ments":[168],"DME,":[170],"based":[172],"on":[173],"our":[174],"recent":[175],"findings":[176],"indicating":[177],"effective":[182],"therapy":[183],"cystoid":[185],"macular":[186],"associated":[188],"uveitis":[190],"(9\u201311),":[191],"we":[192],"decided":[193],"to":[194],"give":[195],"sight-threatening":[198],"refractory":[199],"DME.":[200]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}